Document -
Vironova is part of major effort to advance Sweden’s position in biological drugs
Vironova’s expertise makes us perfectly placed to participate in a major effort for development of biological drugs - recently presented by Vinnova and the Swedish Research Council. Biological structures are complex to work with; the manufacturing process must ensure product quality and needs to be monitored with many analytical methods such as Vironova’s MiniTEM system.
go to media item
- License:
- Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
- File format: